TigerOak Management L.L.C. purchased a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 3,780 shares of the pharmacy operator's stock, valued at approximately $256,000.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Hopwood Financial Services Inc. bought a new position in shares of CVS Health in the fourth quarter worth $29,000. McIlrath & Eck LLC lifted its holdings in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares in the last quarter. Providence First Trust Co bought a new position in CVS Health in the 4th quarter worth about $42,000. Park Square Financial Group LLC bought a new stake in shares of CVS Health during the fourth quarter valued at about $43,000. Finally, PARK CIRCLE Co lifted its holdings in shares of CVS Health by 42.9% in the fourth quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock worth $45,000 after buying an additional 300 shares in the last quarter. 80.66% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Cowen reaffirmed a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Piper Sandler upped their price target on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a report on Friday, March 21st. Royal Bank Of Canada lifted their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Finally, Wells Fargo & Company reiterated an "overweight" rating and set a $84.00 price target (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Two investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and a consensus target price of $74.75.
Check Out Our Latest Report on CVS
Insiders Place Their Bets
In other news, Director Guy P. Sansone bought 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director now owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 1.22% of the company's stock.
CVS Health Price Performance
CVS stock opened at $66.44 on Thursday. The firm has a market cap of $84.05 billion, a P/E ratio of 15.86, a P/E/G ratio of 0.97 and a beta of 0.56. The firm's fifty day moving average is $64.81 and its 200 day moving average is $60.62. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $72.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82.
CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same period last year, the firm earned $1.31 earnings per share. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. Research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.
CVS Health Company Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
